Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 5/2014

01-05-2014 | Letter to the Editor

Low bone density in achondroplasia

Authors: Özlem Taşoğlu, Şule Şahin Onat, Didem Yenigün, Meryem Doğan Aslan, Güldal Funda Nakipoğlu, Neşe Özgirgin

Published in: Clinical Rheumatology | Issue 5/2014

Login to get access

Excerpt

To the editor, …
Literature
1.
Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P et al (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371(6494):252–254PubMedCrossRef
2.
Laederich MB, Horton WA (2010) Achondroplasia: pathogenesis and implications for future treatment. Curr Opin Pediatr 22(4):516–523PubMedCrossRef
3.
Thompson NM, Hecht JT, Bohan TP, Kramer LA, Davidson K, Brandt ME et al (1999) Neuroanatomic and neuropsychological outcome in school-age children with achondroplasia. Am J Med Gen (Neuropsychiatr Genet) 88:145–153CrossRef
4.
Arita ES, Pippa MG, Marcucci M, Cardoso R, Cortes AR, Watanabe PC et al (2013) Assessment of osteoporotic alterations in achondroplastic patients: a case series. Clin Rheumatol 32(3):399–402PubMedCrossRef
5.
Stöss H, Pesch HJ (1985) Structural changes of collagen fibrils in skeletal dysplasias. Ultrastructural findings in the iliac crest. Virchows Arch A Pathol Anat Histopathol 405:341–364PubMedCrossRef
6.
Gutman AB (1959) Serum alkaline phosphatase activity in diseases of skeletal and hepatobiliary systems: consideration of current status. Am J Med 27:875–901PubMedCrossRef
Metadata
Title
Low bone density in achondroplasia
Authors
Özlem Taşoğlu
Şule Şahin Onat
Didem Yenigün
Meryem Doğan Aslan
Güldal Funda Nakipoğlu
Neşe Özgirgin
Publication date
01-05-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 5/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2577-3

Other articles of this Issue 5/2014

Clinical Rheumatology 5/2014 Go to the issue

Original Article

Mean platelet volume as an indicator of disease activity in juvenile SLE

Review Article

Can traumatic injury trigger psoriatic arthritis? A review of the literature

Original Article

Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort

Original Article

Markedly elevated CD64 expressions on neutrophils and monocytes are useful for diagnosis of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome during flares

Review Article

Current evidence on physical therapy in patients with adhesive capsulitis: what are we missing?

Original Article

The predictors of foot ulceration in patients with rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits